LLY

1,142.12

-0.21%↓

JNJ

236.71

+1.9%↑

ABBV

225.17

+1.13%↑

UNH

412.34

+1.63%↑

MRK

119.37

+0.12%↑

LLY

1,142.12

-0.21%↓

JNJ

236.71

+1.9%↑

ABBV

225.17

+1.13%↑

UNH

412.34

+1.63%↑

MRK

119.37

+0.12%↑

LLY

1,142.12

-0.21%↓

JNJ

236.71

+1.9%↑

ABBV

225.17

+1.13%↑

UNH

412.34

+1.63%↑

MRK

119.37

+0.12%↑

LLY

1,142.12

-0.21%↓

JNJ

236.71

+1.9%↑

ABBV

225.17

+1.13%↑

UNH

412.34

+1.63%↑

MRK

119.37

+0.12%↑

LLY

1,142.12

-0.21%↓

JNJ

236.71

+1.9%↑

ABBV

225.17

+1.13%↑

UNH

412.34

+1.63%↑

MRK

119.37

+0.12%↑

Начало・Списък с акции・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Затворен

СекторЗдравеопазване

28.65 1.6

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

28.32

Максимум

29.7

Ключови измерители
By Trading Economics
Приходи	-1.8M -32M
Продажби	6.7M 83M
EPS	-0.56
Марж на печалбата	-38.058
Служители	888
EBITDA	-9.1M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+18.77% upside

Дивиденти
By Dow Jones
Следващи печалби	5.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	250M 1.6B
Предишно отваряне	27.05
Предишно затваряне	28.65

Настроения в новините

By Acuity

50%

153 / 344 Класиране в Healthcare

PROCEPT BioRobotics Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.06.2026 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Fall Following Tech Stock Declines on Wall Street -- Market Talk

9.06.2026 г., 23:45 ч. UTC

Придобивния, сливания и поглъщания

Correct: Sigma Healthcare: Has Engaged in Preliminary Discussions in Boots Sale Process

9.06.2026 г., 23:44 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare Says No Certainty That Any Transaction Will Eventuate

9.06.2026 г., 23:44 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare: Continuously Reviews Opportunities to Create Value For Shareholders

9.06.2026 г., 23:43 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare: Has Engaged in Preliminary Discussions to Sell Boots

9.06.2026 г., 23:35 ч. UTC

Пазарно говорене

Oil Rises on Escalating Supply Disruption Concerns -- Market Talk

9.06.2026 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Element Has Expanded Rapidly Since 2022 Launch of AVITI

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Element to Speed Commercialization of Gene-Sequencing Products

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Additional Investment Makes It Largest Shareholder in Element

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung Electronics Raises Stake in Element Biosciences With $175 Million Investment

9.06.2026 г., 20:51 ч. UTC

Печалби

Micron, Marvell, Super Micro, Coherent, Smucker, and More Stocks That Explain Today's Market -- Barrons.com

9.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.06.2026 г., 20:09 ч. UTC

Пазарно говорене

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9.06.2026 г., 19:36 ч. UTC

Пазарно говорене

Cattle Climbs as Crude Oil Falls -- Market Talk

9.06.2026 г., 19:32 ч. UTC

Пазарно говорене

Barclays Oil Price Outlook Contingent on Hormuz Reopening -- Market Talk

9.06.2026 г., 19:25 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Slip in Rangebound Trade -- Market Talk

9.06.2026 г., 19:00 ч. UTC

Пазарно говорене

Oil Settles Lower on Continued Hopes for Middle East Deal -- Market Talk

9.06.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

Warner Bros. Stock Hits a Low. Its Paramount Merger Return Is Getting Buzz. -- Barrons.com

9.06.2026 г., 18:47 ч. UTC

Пазарно говорене

No World Cup Inflation Seen So Far in Mexico -- Market Talk

9.06.2026 г., 18:37 ч. UTC

Пазарно говорене

Canada's Cooling Trade With the U.S. -- Market Talk

9.06.2026 г., 18:27 ч. UTC

Пазарно говорене

Precious Metals Lower as Trump Vows Military Response -- Market Talk

9.06.2026 г., 17:35 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Briefly Rise on Trump's Iran Retaliation Threat -- Market Talk

9.06.2026 г., 17:30 ч. UTC

Пазарно говорене

Trump Post on Apache Helicopter Causes Brief Spike in Oil -- Market Talk

9.06.2026 г., 16:34 ч. UTC

Пазарно говорене

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

9.06.2026 г., 15:28 ч. UTC

Пазарно говорене

Gold Futures Fall Further as Rate Fears Prevail -- Market Talk

9.06.2026 г., 15:25 ч. UTC

Пазарно говорене

Oil Extends Losses, Falling More Than 3.5% -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

PROCEPT BioRobotics Corp Прогноза

Ценова цел

By TipRanks

18.77% нагоре

12-месечна прогноза

Среден 33.67 USD 18.77%

Висок 51 USD

Нисък 20 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за PROCEPT BioRobotics Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

9 ratings

Купи

Задържане

Продай

Според 9 анализатори, дали борсови рейтинги на PROCEPT BioRobotics Corp през последните 3 месеца.

Настроение

By Acuity

153 / 344 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.